Skip to main content



) --

Cubist Pharmaceuticals



) is trading at unusually high volume Monday with 5.7 million shares changing hands. It is currently at 4.4 times its average daily volume and trading up 82 cents (+2.3%) at $36.64 as of four p.m. ET.

Cubist has a market cap of $2.2 billion and is part of the

health care

sector and


industry. Shares are up 67.4% year to date as of the close of trading on Friday.

Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company has a P/E ratio of 23.2, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Cubist as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full

Cubist Ratings Report


See all heavy volume stocks in our

stocks moving on unusual volume list

or get investment ideas from our

investment research center


Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting


to 95370 or select from

multiple alert options